Trials / Recruiting
RecruitingNCT06776224
Visual (Path)Ways in Multiple Sclerosis - Part II
Evaluation of Neuroaxonal Loss Outside of Any Inflammation in Multiple Sclerosis by a Multimodal Study of the Visual Pathways Model
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system. The mechanisms of neuro-axonal loss remain incompletely elucidated. An acute demyelinating lesion will produce both immediate and delayed axonal loss. Immediate axonal loss is linked to the occurrence of axonal transection. Delayed axonal loss is the cause of axonal degeneration in progressive MS. Visual impairment is common in the disease (vision, oculomotricity, cognition). Through a longitudinal multimodal analysis of visual pathways, we would like to investigate physiopathological mechanisms leading to neurodegenerative process and visual impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Measurement of retinal vascular density and visual cognition | During the same visit, we will perform OCT-angiography (10 minutes) and evaluate visual cognition with an eye-tracker (20 minutes) |
Timeline
- Start date
- 2025-01-24
- Primary completion
- 2026-04-24
- Completion
- 2026-04-24
- First posted
- 2025-01-15
- Last updated
- 2025-01-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06776224. Inclusion in this directory is not an endorsement.